$AXSM insider trading

Over the last 12 months, Axsome Therapeutics insiders reported no purchases and 10 sales totaling $46.8M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.

$46.8M
10
5
100%
Side
$100K$1.0M$10M$100MMay '26JunJulAug
Coleman Mark
TABUTEAU HERRIOT
JEFFS ROGER
Mahony Susan
Pizzie Nick

All insider trades

Aug 6, 2026TABUTEAU HERRIOT▼ Sale49,664$212.19$10.5M-87.3%
Jul 1, 2026TABUTEAU HERRIOT▼ Sale49,666$240.25$11.9M-87.3%
Jun 11, 2026JEFFS ROGER▼ Sale572$247.65$142K-1%
Jun 10, 2026Mahony Susan▼ Sale600$241.7$145K-42%
Jun 10, 2026Coleman Mark▼ Sale643$249$160K-2.1%
Jun 9, 2026TABUTEAU HERRIOT▼ Sale49,670$241.01$12.0M-87.3%
Jun 9, 2026Pizzie Nick▼ Sale33,000$240.09$7.9M-43.5%
Jun 2, 2026Coleman Mark▼ Sale5,537$223.39$1.2M-15.8%
Jun 1, 2026Coleman Mark▼ Sale6,000$230.3$1.4M-14.6%
May 29, 2026Coleman Mark▼ Sale6,000$233.46$1.4M-12.7%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $AXSM feed.

AXSM Insider Trading — Form 4 Buys & Sells | alphai